Author:
Sun Chongpeng,Wang Shiyang,Chatterjee Aritrick,Medved Milica,Eggener Scott,Karczmar Gregory S.,Oto Aytekin
Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine
Reference34 articles.
1. Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30
2. Stamey TA, Caldwell M, McNeal JE, Nolley R, Hemenez M, Downs J (2004) The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol 172:1297–1301
3. American Cancer Society (2018) Cancer facts & figures 2018. American Cancer Society, Atlanta. Available via: http://www.cancer.org/research/cancer-facts-statistics.html. Accessed 12 April 2018
4. Polascik TJ, Mayes JM, Sun L, Madden JF, Moul JW, Mouraviev V (2008) Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy. Prostate 68:1380–1386
5. Esserman LJ, Thompson IM, Reid B et al (2014) Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol 15:e234–e242
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献